Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP117197.RA-jO_a2gPb41iqNrtYThsv-cMcC17rbM3XOeAm5uiZ68130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP117197.RA-jO_a2gPb41iqNrtYThsv-cMcC17rbM3XOeAm5uiZ68130_assertion type Assertion NP117197.RA-jO_a2gPb41iqNrtYThsv-cMcC17rbM3XOeAm5uiZ68130_head.
- NP117197.RA-jO_a2gPb41iqNrtYThsv-cMcC17rbM3XOeAm5uiZ68130_assertion description "[However, our data indicate that MS patients who carry the activating KIR2DS2 and the inhibitory KIR2DL2 genes have more severe disease than patients not carrying these genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP117197.RA-jO_a2gPb41iqNrtYThsv-cMcC17rbM3XOeAm5uiZ68130_provenance.
- NP117197.RA-jO_a2gPb41iqNrtYThsv-cMcC17rbM3XOeAm5uiZ68130_assertion evidence source_evidence_literature NP117197.RA-jO_a2gPb41iqNrtYThsv-cMcC17rbM3XOeAm5uiZ68130_provenance.
- NP117197.RA-jO_a2gPb41iqNrtYThsv-cMcC17rbM3XOeAm5uiZ68130_assertion SIO_000772 19630074 NP117197.RA-jO_a2gPb41iqNrtYThsv-cMcC17rbM3XOeAm5uiZ68130_provenance.
- NP117197.RA-jO_a2gPb41iqNrtYThsv-cMcC17rbM3XOeAm5uiZ68130_assertion wasDerivedFrom gad-20150221 NP117197.RA-jO_a2gPb41iqNrtYThsv-cMcC17rbM3XOeAm5uiZ68130_provenance.
- NP117197.RA-jO_a2gPb41iqNrtYThsv-cMcC17rbM3XOeAm5uiZ68130_assertion wasGeneratedBy ECO_0000203 NP117197.RA-jO_a2gPb41iqNrtYThsv-cMcC17rbM3XOeAm5uiZ68130_provenance.